Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 公司所处行业为中药制造业，主营业务为中成药及大健康产品的研发、生产和销售，中药材种植和销售，中药饮片加工和销售，防护口罩等医疗器械的生产和销售，以及分析检测服务业务。 公司拥有药品批准文号467个，常年生产丸剂、片剂、颗粒剂、胶囊剂、胶剂等11种剂型的110多种产品，拥有参茸固本还少丸、复方黄芪健脾口服液等10个独家产品。目前，公司生产销售的主要产品有六味地黄丸、逍遥丸、香砂养胃丸、参茸固本还少丸、阿胶等中成药以及中药饮片、大健康产品，涵盖了补益、感冒、肠胃、妇科、安神睡眠等多个类别和领域。
Main Business 中成药及大健康产品的研发、生产和销售，中药材种植和销售，中药饮片加工和销售，防护口罩等医疗器械的生产和销售，以及分析检测服务业务。
Legal Representative 单小东
Top Executives
董事长：单小东
董事：钱双喜,王新海,王迎春
独立董事：贾洪文,李志刚,胡花芸
Top 5 Shareholder
Shareholder name Nature Holding Date
兰州佛慈医药产业发展集团有限公司流通A股61.63%30/09/2024
甘肃省国有资产投资集团有限公司流通A股0.80%30/09/2024
香港中央结算有限公司流通A股0.56%30/09/2024
郑木平流通A股0.54%30/09/2024
赵金芳流通A股0.54%30/09/2024
Company Secretary --
Solicitors 甘肃经天地律师事务所
Auditors 瑞华会计师事务所（特殊普通合伙）
Tel No 0931-8256881;0931-8362318
Fax No 0931-83622318
Website www.fczy.com
Email wangjunhui@fczy.cn；anwenting_fczy@163.com；zqb@fczy.com
Company Address
Register: 甘肃省兰州新区华山路2289号
Office: 甘肃省兰州新区华山路2289号
Listing Date 22/12/2011
Shares Capital
Shares Capital: 510,657,000
Total A Share: 510,657,000
Listed A Share: 510,657,000
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.132
DPS(RMB)* ¥ 0.030
NBV Per Share(RMB)* ¥ 3.418
Market Capitalization(RMB) 3.830B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.